Open AccessExpression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status
Author(s) -
Gnanapriya Vellaisamy,
Rajalakshmi Tirumalae,
YK Inchara
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_572_17
Subject(s) - lymphovascular invasion , progesterone receptor , androgen receptor , medicine , immunohistochemistry , estrogen receptor , context (archaeology) , carcinoma , breast carcinoma , estrogen , pathology , ductal carcinoma , metastasis , oncology , breast cancer , cancer , biology , prostate cancer , paleontology
The role of estrogen/progesterone receptors (ER/PR) is well-established with respect to therapy and prognosis of breast carcinoma. However, the role of androgen receptor (AR) expression is unclear in the Indian context. The objective is to study the following: (a) Expression of AR in resection specimens of ductal carcinomas, (b) Relationship of AR with clinicopathologic features, ER, PR, and Her-2 status.